Overview

Pharmacokinetic Interactions and Safety Study of Telmisartan and Chlorthalidone

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
Clinical trial to evaluate the pharmacokinetic interactions and safety between telmisartan and chlorthalidone.
Phase:
Phase 1
Details
Lead Sponsor:
HanAll BioPharma Co., Ltd.
Treatments:
Chlorthalidone
Telmisartan